Insights into the physiological role of WT1 from studies of genetically modified mice

被引:33
作者
Discenza, MT
Pelletier, J
机构
[1] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada
[2] McGill Univ, McGill Canc Ctr, Montreal, PQ H3G 1Y6, Canada
关键词
kidney development; mouse models;
D O I
10.1152/physiolgenomics.00164.2003
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The identification of WT1 gene mutations in children with WAGR and Denys-Drash syndromes pointed toward a role for WT1 in genitourinary system development. Biochemical analysis of the different WT1 protein isoforms showed that WT1 is a transcription factor and also has the ability to bind RNA. Analysis of WT1 complexes identified several target genes and protein partners capable of interacting with WT1. Some of these studies placed WT1, its downstream targets, and protein partners in a transcriptional regulatory network that controls urogenital system development. We review herein studies on WT1 knockout and transgenic models that have been instrumental in defining a physiological role for WT1 in normal and abnormal urogenital development.
引用
收藏
页码:287 / 300
页数:14
相关论文
共 145 条
[1]   THE EXPRESSION OF THE WILMS-TUMOR GENE, WT1, IN THE DEVELOPING MAMMALIAN EMBRYO [J].
ARMSTRONG, JF ;
PRITCHARDJONES, K ;
BICKMORE, WA ;
HASTIE, ND ;
BARD, JBL .
MECHANISMS OF DEVELOPMENT, 1993, 40 (1-2) :85-97
[2]  
Baird Paul N., 1992, Human Molecular Genetics, V1, P301, DOI 10.1093/hmg/1.5.301
[3]  
BAIRD PN, 1992, ONCOGENE, V7, P2141
[4]   Donor splice-site mutations in WT1 are responsible for Frasier syndrome [J].
Barbaux, S ;
Niaudet, P ;
Gubler, MC ;
Grunfeld, JP ;
Jaubert, F ;
Kuttenn, F ;
Fekete, CN ;
SouleyreauTherville, N ;
Thibaud, E ;
Fellous, M ;
McElreavey, K .
NATURE GENETICS, 1997, 17 (04) :467-470
[5]   Overlapping RNA and DNA binding domains of the wt1 tumor suppressor gene product [J].
Bardeesy, N ;
Pelletier, J .
NUCLEIC ACIDS RESEARCH, 1998, 26 (07) :1784-1792
[6]  
BARDEESY N, 1995, CANCER RES, V55, P215
[7]   ANAPLASTIC WILMS-TUMOR, A SUBTYPE DISPLAYING POOR-PROGNOSIS, HARBORS P53 GENE-MUTATIONS [J].
BARDEESY, N ;
FALKOFF, D ;
PETRUZZI, MJ ;
NOWAK, N ;
ZABEL, B ;
ADAM, M ;
AGUIAR, MC ;
GRUNDY, P ;
SHOWS, T ;
PELLETIER, J .
NATURE GENETICS, 1994, 7 (01) :91-97
[8]  
BECKWITH J B, 1990, Pediatric Pathology, V10, P1
[9]  
BENNINGTON JL, 1975, ATLAS TUMOR PATHOL 2
[10]  
BROWN KW, 1992, ONCOGENE, V7, P763